If an entity measures any individual biological assets at cost in accordance with
paragraph 34.6A, it shall explain why fair value cannot be reliably measured. If the fair
value of such a biological asset becomes reliably measurable during the current period
an entity shall explain why fair value has become reliably measurable and the effect of
the change.